One of the initiative Data 42, called as ‘moonshot’ project within Novartis, is trying to harness the power of data analytics, machine learning and AI to possibly find leads for new drugs, new patient approaches and identifying safety features, by wringing new insights out of old clinical trials data.Novartis leads the way in using data and AI to find new drugs, improve RD productivity
One of the initiative Data 42, called as ‘moonshot’ project within Novartis, is trying to harness the power of data analytics, machine learning and AI to possibly find leads for new drugs, new patient approaches and identifying safety features, by wringing new insights out of old clinical trials data.
Subscribe to:
Post Comments (Atom)
-
The company, one of the leading manufacturers of soda ash, had initiated the process of carving out its textiles business into GHCL Textile...
-
The BRLLR linked to RBI Repo Rate is revised downwards in line with the reduction on Reserve Bank of India Repo Rate from 5.15 percent to 4...
-
The company did not export units last month while it had dispatched 804 Etios units in in June 2019.
No comments:
Post a Comment